Peak Bio
Scope
Date
~
-
Automobiles
Hyundai Motor unveils 2024 Staria Hybrid
Hyundai Motor Co. announced on Wednesday that it will begin pre-orders for the upcoming Staria Hybrid model and the 2024 Staria on Feb. 28. H...
Feb 28, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung targets gene therapy sector through US investments
Samsung Group is targeting the gene therapy business through investments in US biotechnology companies as the leading South Korean conglomerate is s...
Feb 27, 2024 (Gmt+09:00)
-
Artificial intelligence
LG to use AI for early detection of air conditioner anomalies
LG Electronics Inc. has introduced an artificial intelligence technology for early detection of anomalies in its commercial air conditioning systems...
Feb 20, 2024 (Gmt+09:00)
-
Chemical Industry
LG Chem, CJ CheilJedang to launch eco-friendly bio-nylon joint venture
South Korea’s top chemicals maker LG Chem Ltd. and food and biotechnology firm CJ CheilJedang Corp. have agreed to launch an eco-friendly bio-...
Feb 15, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics signs ADC CDO deal with LegoChem Bio
Samsung Biologics Co. has agreed with South Korean biotech company LegoChem Biosciences Inc. to provide contract development organization (CDO) serv...
Feb 07, 2024 (Gmt+09:00)
-
Beauty & Cosmetics
Cosmax opens integrated R&D center for bio-material
Cosmax Group, South Korea's largest cosmetics manufacturer specializing in original design manufacturing (ODM), announced on Monday that it has la...
Feb 05, 2024 (Gmt+09:00)
-
Infrastructure
Digital assets emerge as Korean LPs' No. 1 infrastructure target
Digital infrastructure, such as data centers, towers and smart meters, will be the hottest infrastructure asset this year for South Korean limited par...
Jan 31, 2024 (Gmt+09:00)
-
Alternative investments
Peak views: What lies ahead in 2024?
With 2023 at a close, financial markets are at an important junction. Major developed market central banks have paused their rate rises and there ...
Jan 25, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion, WuXi XDC to develop new antibody-drug conjugates
South Korea’s Celltrion Inc. has signed a business agreement with China’s WuXi XDC to jointly develop new antibody-drug conjugates (ADC)...
Jan 24, 2024 (Gmt+09:00)
-
Bio & Pharma
Lotte Biologics, NJ Bio to jointly develop ADC
South Korea's Lotte Biologics Co. announced on Monday that it has signed a strategic business agreement with NJ Bio, a US-based preclinical and clin...
Jan 22, 2024 (Gmt+09:00)
-
Bio & Pharma
Biopharma M&As: Next big thing for South Korean manufacturers
When Orion Corp., known for its signature snack cake Choco-Pie, announced a $415 million deal to acquire biotech startup LegoChem Biosciences Inc. l...
Jan 22, 2024 (Gmt+09:00)
-
Central bank
BOK hints at policy rate peak but in no hurry to cut rates
South Korea’s central bank on Thursday hinted its policy rate may have peaked after leaving the rate unchanged for the eighth straight meeting...
Jan 11, 2024 (Gmt+09:00)
-
Bio & Pharma
LegoChem Bio, Janssen sign $1.7 bn ADC licensing deal
LegoChem Biosciences Inc. has signed a blockbuster $1.7 billion deal to license out its proprietary antibody drug conjugate (ADC) candidate to Jasse...
Dec 26, 2023 (Gmt+09:00)
-
Corporate strategy
Samsung launches new growth engine control tower at mobile division
Samsung Electronics Co., the world’s largest maker of memory chips and smartphones, has created a business control tower within its Digital eX...
Dec 11, 2023 (Gmt+09:00)
-
Bio & Pharma
LegoChem Bio mulls name change after defeat to Lego
South Korean biopharmaceutical company LegoChem Biosciences Inc. is seeking to change its name after it lost in a trademark infringement lawsuit fil...
Dec 08, 2023 (Gmt+09:00)
-
Travel & Leisure
Seoul to add new aerial lifts to Namsan by 2025
Visitors to Seoul, the capital of South Korea, are expected to enjoy faster and easier exploration of the city’s famous Namsan Mountain in 202...
Dec 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Access Bio opens second plant in New Jersey
The US-based in-vitro diagnostic device company Access Bio Inc. announced on Monday that it opened its second factory in Monroe Township, New Jersey...
Dec 04, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea to invest $200 mn in new drugs, vaccines by 2028
South Korea’s health ministry will allocate 261.6 billion won ($200.2 million) for two funds over the next four years to boost private sector ...
Nov 24, 2023 (Gmt+09:00)
-
Batteries
LG Chem, SNU to jointly develop next-generation material
South Korea's LG Chem Ltd. partnered with Seoul National University (SNU) to develop next-generation material technologies, including pivotal materi...
Nov 17, 2023 (Gmt+09:00)
-
Bio & Pharma
South Korean bio, pharma industry set to take leap
South Korea’s chemical maker LG Chem Ltd. is expected to reap more than 1 trillion won ($768.5 million) in sales this year from its new growth...
Nov 15, 2023 (Gmt+09:00)
-
Bio & Pharma
'World-class bispecific antibody technology of ABL Bio'
MADRID - "The clinical Phase 1 results of the immune-oncology candidate ABL111, developed in collaboration with ABL Bio, have been selected as the b...
Nov 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Engineering secures $349 mn bio plant deal
South Korea's Samsung Engineering secured a deal for the Songdo Bio Raw Material Plant construction project from the global life sciences and labora...
Nov 01, 2023 (Gmt+09:00)
-
Carbon neutrality
HD Hyundai Oilbank secures bio-based material supply network
South Korea's HD Hyundai Oilbank announced on Tuesday it signed contracts with Indonesia's Korindo Group and Korea's LX International for the purcha...
Oct 31, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics partners with Europe's largest VC
Samsung Biologics Co., the world's largest contract drug manufacturer, announced on Tuesday it has teamed up with global biotech venture capitalist ...
Oct 24, 2023 (Gmt+09:00)
-
Bio & Pharma
VaxCell-Bio applies for approval of anti-cancer drug for dogs
South Korea’s VaxCell Biotherapeutics Co. (VaxCell-Bio) on Tuesday announced its application for approval for Vaxleukin-15, an anti-cancer dru...
Oct 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Humedix gets gov't OK for trials of dementia candidate drug
South Korea’s Humedix Co., a developer of biological and pharmaceutical products, on Tuesday said it received approval from the Ministry of Fo...
Oct 18, 2023 (Gmt+09:00)
-
Bio & Pharma
Johnson & Johnson more interested in Korean bio startups
Johnson & Johnson, a global pharmaceutical giant, showed more interest in South Korean bio startups with competitive innovation despite the rece...
Oct 17, 2023 (Gmt+09:00)
-
Carbon neutrality
SK to invest in S.Korean company for bio jet fuel materials
SK Group, South Korea’s energy-to-semiconductor conglomerate, is set to invest in a local renewable energy ingredient provider for stable proc...
Oct 17, 2023 (Gmt+09:00)
-
Chemical Industry
LG Chem, GS Caltex form eco-friendly materials alliance
LG Chem Ltd. and GS Caltex Corp. are accelerating their efforts in the eco-friendly bio-material business involving 3-hydroxypropionic acid (3HP). 3...
Oct 13, 2023 (Gmt+09:00)
-
Travel & Leisure
Overseas trips top pre-pandemic levels during Chuseok holiday
The number of South Koreans who spent this year’s six-day holiday of Chuseok abroad exceeded pre-pandemic levels, indicating a recovery in the...
Oct 08, 2023 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand